QIAGEN NV EO -,01 | 43.900 / +0.43% |
Date/Time | 01/15 / 19:34 |
Chg. / Chg.(%) | 0.190 / +0.43% |
Bid | - |
Ask | - |
Open | 43.710 |
Previous Close | 43.710 |
High | 43.900 |
Low | 43.710 |
Volume [EUR] | 219.500 |
Volume [Units] | 5 |
Price fixings | 2 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | München |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 44.03 | ![]() |
1,015,941 |
NYSE | 53.20 | ![]() |
558,237 |
Xetra | 44.060 | ![]() |
307,028 |
Cboe Europe .. | 44.05 | ![]() |
143,769 |
Turquoise | 44.04 | ![]() |
24,395 |
TradeGate | 43.82 | ![]() |
13,419 |
Cboe US | 53.11 | ![]() |
11,857 |
Frankfurt | 44.0000 | ![]() |
6,125 |
IEX | 53.19 | ![]() |
5,873 |
Cboe Europe .. | 43.94 | ![]() |
1,914 |
Stuttgart | 43.820 | ![]() |
1,412 |
Cboe Europe .. | 43.93 | ![]() |
1,029 |
Hamburg | 43.840 | ![]() |
640 |
gettex | 44.040 | ![]() |
254 |
Berlin | 43.930 | ![]() |
145 |
Düsseldorf | 43.930 | ![]() |
60 |
München | 43.900 | ![]() |
5 |
Vienna Globa.. | 44.04 | ![]() |
0 |
Hannover | 43.780 | ![]() |
0 |
Lang & Schwa.. | 43.770 | ![]() |
|
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire